Malta - Ingliż - Medicines Authority

smithkline beecham limited - pertactin; pertussis filamentous haemagglutinin; pertussis toxoid; poliovirus (inactivated) type 1 (mahoney strain); poliovirus (inactivated) type 2 (mef-1 strain); poliovirus (inactivated) type 3 (saukett strain); diphtheria toxoid; haemophilus influenzae type b polysaccharide (polyribosylribitol phosphate); tetanus toxoid - powder and suspension for suspension for injection - pertactin 8 µg; pertussis filamentous haemagglutinin 25 µg; pertussis toxoid 25 µg; poliovirus (inactivated) type 1 (mahoney strain) 40 dagu/0.5ml; poliovirus (inactivated) type 2 (mef-1 strain) 8 dagu/0.5ml; poliovirus (inactivated) type 3 (saukett strain) 32 dagu/0.5ml; diphtheria toxoid; haemophilus influenzae type b polysaccharide (polyribosylribitol phosphate) 10 µg; tetanus toxoid - vaccines

Filippini - Ingliż - FDA (Food And Drug Administration)

n/a; importer: sanofi pasteur, inc; distributor: zuellig pharma corporation - diphtheria, tetanus, pertussis (acellular poliomyelitis (inactivated) vaccine and haemophilus influenzae type b conjugate vaccine (adsorbed) - suspension and powder for suspension for injection (im) - after reconstitution, each dose (0.5 ml) contains: diphtheria toxoid tetanus toxoid bordetella pertussis antigen pertussis toxoid filamentous hemagglutinin poliovirus (inactivated) >30 iu >40 iu polysaccharide influenzae type b conjugated to tetanus protein of haemophilus 10 mcg 18-30 mcg 25 mcg 25 mcg type i poliomyelitis virus (inactivated) 40 d antigen units type ii poliomyelitis virus (inactivated) 8 d antigen units type iii poliomyelitis virus (inactivated) 32 d' antigen

Filippini - Ingliż - FDA (Food And Drug Administration)

n/a; importer: sanofi pasteur, inc.; distributor: zuellig pharma corporation - diphtheria, tetanus, pertussis (acellular component), hepatitis b, poliomyelitis (inactivated) and haemophilus influenzae type b conjugate vaccine (adsorbed) - suspension for injection (im) - formulation: each dose (0.5 ml) contains: diphtheria toxoid' tetanus toxoid ' bordetella pertussis antigen pertussis toxoid' filamentous hemagglutinin' poliovirus (inactivated)2.3 type i (mahoney) strain nlt 20 iu nlt 40 iu hepatitis b surface antigen haemophilus influenzae type b polysaccharide phosphate) 10 mcg (polyribosylribitol 12 mcg conjugate to tetanus protein 22-36 mcg 25 mcg 25 mcg 40 d antigen units type ii (mef-1) strain" type iii (saukett) strain1 8 d antigen units 32 d antigen units 'adsorbed on aluminium hydroxide, hydrated (al(oh)3) 2produced in yeast cells (saccharomyces cerevisiae) by recombinant dna technology 3adsorbed on aluminium phosphate (aipo4) *propagated in vero cells

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

hologic (australia & new zealand) pty ltd - ct778 - bordetella ivds - the panther fusion bordetella assay is a multiplex real-time pcr in vitro diagnostic test for the rapid and qualitative detection and differentiation of bordetella pertussis (bp) and bordetella parapertussis (bpp). this assay is intended to aid in the differential diagnosis of bordetella pertussis and bordetella parapertussis infections in humans.

Awstralja - Ingliż - APVMA (Australian Pesticides and Veterinary Medicines Authority)

boehringer ingelheim animal health australia pty. ltd. - canine parainfluenza; bordetella bronchiseptica; canine adeno virus type 2 - misc. vaccines or anti sera - canine parainfluenza vaccine active 0.0 p; bordetella bronchiseptica vaccine-microbial active 0.0 p; canine adeno virus type 2 vaccine-viral active 0.0 p - immunotherapy - dog - over 8 weeks - bordetella bronchiseptica | canine adenovirus - type 2 | canine parainfluenza | canine cough syndrome | infectious tracheobronchitis

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - pertussis filamentous haemagglutinin, quantity: 10 microgram/ml; pertussis fimbriae 2 + 3, quantity: 10 microgram/ml; tetanus toxoid, quantity: 80 iu/ml; pertussis toxoid, quantity: 20 microgram/ml; diphtheria toxoid, quantity: 60 iu/ml; pertactin, quantity: 6 microgram/ml - injection, suspension - excipient ingredients: aluminium phosphate; water for injections; phenoxyethanol - tripacel is indciated for primary immunisation against diphtheria, tetanus and pertussis when commenced between 2 months and 12 months of age. tripacel is also indicated for the fourth and fifth dose for children from 15 months of age up to their eighth birthday who have been immunised previously with three or four doses of diphtheria, tetanus and pertussis (whole cell or acellular) vaccines.

Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

aj vaccines a/s - diphtheria toxoid, purified; tetanus toxoid, purified; pertussis toxoid, purified - suspension for injection in pre-filled syringe - < 2 international unit(s) - pertussis vaccines; pertussis, purified antigen, combinations with toxoids

Belġju - Ingliż - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sanofi pasteur europe s.a. - bordetella pertussis toxoid (pt) ; diphtheria toxoid (dt) >= 2 iu/0,5 ml; bordetella pertussis purified fimbrial agglutinogens 2 and 3 (fim) ; bordetella pertussis pertactin ; bordetella pertussis filamentous hemagglutinin (fha) ; aluminium phosphate 1,5 mg/0,5 ml; tetanus toxoid >= 20 iu/0,5 ml - suspension for injection in pre-filled syringe - tetanus toxoid adsorbed; diphteria antigen, adsorbed; bordetella pertussis antigen, adsorbed - pertussis, purified antigen, combinations with toxoids

Belġju - Ingliż - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

glaxosmithkline biologicals sa-nv - bordetella pertussis filamentous hemagglutinin (fha) 8 µg/dose; diphtheria toxoid (dt) >= 2 iu/dose; bordetella pertussis toxoid (pt) 8 µg/dose; bordetella pertussis pertactin 2,5 µg/dose; tetanus toxoid >= 20 iu/dose - suspension for injection - diphteria antigen, adsorbed; tetanus toxoid adsorbed; bordetella pertussis - pertussis, purified antigen, combinations with toxoids

Belġju - Ingliż - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

glaxosmithkline biologicals sa-nv - bordetella pertussis filamentous hemagglutinin (fha) 8 µg/dose; diphtheria toxoid (dt) >= 2 iu/dose; bordetella pertussis toxoid (pt) 8 µg/dose; bordetella pertussis pertactin 2,5 µg/dose; tetanus toxoid >= 20 iu/dose - suspension for injection - diphteria antigen, adsorbed; tetanus toxoid adsorbed; bordetella pertussis - pertussis, purified antigen, combinations with toxoids